*****Biologically active according to Changlu Liu - Ph.D Johnson & Johnson Pharmaceutical Research and Development San Diego*****
Links to publications that use this peptide:
McGowan et al. Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis.Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E278-86.
El-Shewy et al. The Insulin-like Growth Factor Type 1 and Insulin-like Growth Factor Type 2/Mannose-6-phosphate Receptors Independently Regulate ERK1/2 Activity in HEK293 Cells J Biol Chem. 2007 Sep 7;282(36):26150-7.
McGowan et al. Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar ratsAm J Physiol Endocrinol Metab. 2007 Mar;292(3):E913-9.
Bennett et al. Relaxin receptors in hepatic stellate cells and cirrhotic liver. Biochem Pharmacol. 2007 Apr 1;73(7):1033-40.
Hida et al. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats.J Recept Signal Transduct Res. 2006;26(3):147-58.
Bennett et al. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. Ann N Y Acad Sci. 2005 May;1041:185-9.
035-36a
